Ryu CK - Search Results

1

Induction of cytochrome P450 1A1 gene expression by a vitamin K3 analog in mouse hepatoma Hepa-1c1c7 cells.

Chun YJ, Lee BY, Yang SA, Ryu CK, Kim MY. Chun YJ, et al. Among authors: ryu ck. Mol Cells. 2001 Oct 31;12(2):190-6. Mol Cells. 2001. PMID: 11710520 Free article.

2

5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents.

Ryu CK, Kang HY, Lee SK, Nam KA, Hong CY, Ko WG, Lee BH. Ryu CK, et al. Bioorg Med Chem Lett. 2000 Mar 6;10(5):461-4. doi: 10.1016/s0960-894x(00)00014-7. Bioorg Med Chem Lett. 2000. PMID: 10743948

3

Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide.

Park YG, Park S, Lim SO, Lee MS, Ryu CK, Kim I, Cho-Chung YS. Park YG, et al. Among authors: ryu ck. Biochem Biophys Res Commun. 2001 Mar;281(5):1213-9. doi: 10.1006/bbrc.2001.4521. Biochem Biophys Res Commun. 2001. PMID: 11243864

4

Modulation of Nad(P)H:quinone oxidoreductase (NQO1) activity mediated by 5-arylamino-2-methyl-4,7-dioxobenzothiazoles and their cytotoxic potential.

Ryu CK, Jeong HJ, Lee SK, Kang HY, Ko KM, Sun YJ, Song EH, Hur YH, Lee CO. Ryu CK, et al. Arch Pharm Res. 2000 Dec;23(6):554-8. doi: 10.1007/BF02975239. Arch Pharm Res. 2000. PMID: 11156173

5

Cytotoxic activities of 6-arylamino-7-halo-5,8-quinolinediones against human tumor cell lines.

Ryu CK, Kang HY, Yi YJ, Lee CO. Ryu CK, et al. Arch Pharm Res. 2000 Feb;23(1):42-5. doi: 10.1007/BF02976464. Arch Pharm Res. 2000. PMID: 10728655

6

Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.

Chang TS, Kim HM, Lee KS, Khil LY, Mar WC, Ryu CK, Moon CK. Chang TS, et al. Among authors: ryu ck. Biochem Pharmacol. 1997 Jul 15;54(2):259-68. doi: 10.1016/s0006-2952(97)00179-2. Biochem Pharmacol. 1997. PMID: 9271330

7

Synthesis and antifungal activities of 5/6-arylamino-4,7-dioxobenzothiazoles.

Ryu CK, Kang HY, Yi YJ, Shin KH, Lee BH. Ryu CK, et al. Bioorg Med Chem Lett. 2000 Jul 17;10(14):1589-91. doi: 10.1016/s0960-894x(00)00301-2. Bioorg Med Chem Lett. 2000. PMID: 10915058

8

6-arylamino-5,8-quinolinediones and 7-arylamino-5,8-isoquinolinediones as inhibitors of endothelium-dependent vasorelaxation.

Ryu CK, Jung SH, Lee JA, Kim HJ, Lee SH, Chung JH. Ryu CK, et al. Bioorg Med Chem Lett. 1999 Sep 6;9(17):2469-72. doi: 10.1016/s0960-894x(99)00411-4. Bioorg Med Chem Lett. 1999. PMID: 10498190

9

Pharmacokinetics, stability, and blood partition of 7-anilino-5,8-isoquinolinedione, a new isoquinonlinedione derivative.

Kim SH, Moon YJ, Ryu CK, Lee MG. Kim SH, et al. Among authors: ryu ck. Res Commun Mol Pathol Pharmacol. 2000 May-Jun;107(5-6):419-29. Res Commun Mol Pathol Pharmacol. 2000. PMID: 11589368

10

Synthesis and cytotoxic activities of 6-chloro-7-arylamino-5,8-isoquinolinediones.

Ryu CK, Lee IK, Jung SH, Lee CO. Ryu CK, et al. Bioorg Med Chem Lett. 1999 Apr 19;9(8):1075-80. doi: 10.1016/s0960-894x(99)00152-3. Bioorg Med Chem Lett. 1999. PMID: 10328288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters